Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CTMX
#2162
CytomX Therapeutics, Inc.
5.3
7
-0.37%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.37%
Monthly Change
-9.60%
6 month change
+156.94%
Cambio anual
+701.49%
Cierres anteriores
5.3
9
Open
5.3
7
Bid
Ask
Low
5.3
7
High
5.3
7
Volumen
86
Markets
Acciones
Atención Sanitaria
CTMX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
CytomX en Cumbre Guggenheim: Prometedor tratamiento para cáncer colorrectal
CytomX en la Cumbre de Guggenheim: Prometedor camino para tratamiento de CRC
CytomX at Guggenheim Summit: Promising CRC Treatment Path
Qiagen (QGEN) Meets Q4 Earnings Estimates
Las acciones de CytomX Therapeutics alcanzan un máximo de 52 semanas a 6,16 dólares
CytomX Therapeutics stock hits 52-week high at 6.16 USD
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data
CytomX Stock Rises 31% in a Month: Here's What You Should Know